Dermatology OTC Medications Market

Dermatology drug is used in the management and treatment of diseases related to skin. Acne, psoriasis, and dermatitis are some common skin diseases. Over-the-counter (OTC) drugs are medicines sold directly to a consumer without a prescription from a healthcare professional, as opposed to prescription drugs, which may be sold only to consumers possessing a valid prescription.

Dermatology OTC Medications Market contains market size and forecasts of Dermatology OTC Medications in global, including the following market information:

Global Dermatology OTC Medications Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Dermatology OTC Medications Market Sales, 2017-2022, 2023-2028, (M Units)

Global top five Dermatology OTC Medications companies in 2021 (%)

The global Dermatology OTC Medications market was valued at 13150 million in 2021 and is projected to reach US$ 16350 million by 2028, at a CAGR of 3.2% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

External Use Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Dermatology OTC Medications include Bayer, GSK, Teva, Johnson & Johnson, Novartis, Mylan, Sun Pharmaceutical, Aurobindo and Galderma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Dermatology OTC Medications manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Dermatology OTC Medications Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (M Units)

Global Dermatology OTC Medications Market Segment Percentages, by Type, 2021 (%)

External Use

Oral

Global Dermatology OTC Medications Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (M Units)

Global Dermatology OTC Medications Market Segment Percentages, by Application, 2021 (%)

Hospital

Drug Store

Other

Global Dermatology OTC Medications Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (M Units)

Global Dermatology OTC Medications Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Dermatology OTC Medications revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Dermatology OTC Medications revenues share in global market, 2021 (%)

Key companies Dermatology OTC Medications sales in global market, 2017-2022 (Estimated), (M Units)

Key companies Dermatology OTC Medications sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Bayer

GSK

Teva

Johnson & Johnson

Novartis

Mylan

Sun Pharmaceutical

Aurobindo

Galderma

CR SANJIU

Dr. Reddy's

Lupin

Bausch Health

Cipla

Qilu Pharmaceutical

Almirall

Lingrui